Nanobiotix S.A. Current Accrued Expenses And Other Current Liabilities
Nanobiotix S.A. (NNBXF) had Current Accrued Expenses And Other Current Liabilities of EUR 2.54 million as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities · last filed 2026-03-31
- 2025-12-31: Current Accrued Expenses And Other Current Liabilities 2.54M EUR.
- 2025-06-30: Current Accrued Expenses And Other Current Liabilities 7.41M EUR.
- 2024-12-31: Current Accrued Expenses And Other Current Liabilities 15.55M EUR.
- 2024-06-30: Current Accrued Expenses And Other Current Liabilities 14.37M EUR.
| Period end | Current Accrued Expenses And Other Current Liabilities | Current Accrued Expenses And Other Current Liabilities as first filed |
|---|---|---|
| 2025-12-31 | 2.54M EUR 20-F · filed 2026-03-31 | |
| 2025-06-30 | 7.41M EUR 6-K · filed 2025-09-30 | |
| 2024-12-31 | 15.55M EUR 20-F · filed 2026-03-31 | |
| 2024-06-30 | 14.37M EUR 6-K · filed 2024-09-18 | |
| 2023-12-31 | 11.37M EUR 20-F · filed 2025-04-02 | |
| 2022-12-31 | 5.39M EUR 20-F · filed 2024-04-24 | 3.90M EUR 20-F · filed 2023-04-24 |
| 2021-12-31 | 3.90M EUR 20-F · filed 2023-04-24 |